We are live on ! Find out more
Stifel Financial

Stifel Financial Portfolio holdings

AUM $109B
1-Year Est. Return 21.36%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$66.6B
AUM Growth
+$5.55B
Cap. Flow
+$370M
Cap. Flow %
0.55%
Top 10 Hldgs %
14.79%
Holding
3,449
New
177
Increased
1,464
Reduced
1,530
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 14.39%
2 Healthcare 12.41%
3 Industrials 9.84%
4 Consumer Staples 9.52%
5 Financials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXM icon
3001
Sprinklr
CXM
$1.56B
$181K ﹤0.01%
22,109
-1,606
-7% -$13.9K
RMI
3002
RiverNorth Opportunistic Municipal Income Fund
RMI
$101M
$180K ﹤0.01%
+11,010
New +$179K
SIRI icon
3003
SiriusXM
SIRI
$10.2B
$180K ﹤0.01%
3,078
-152
-5% -$9.35K
SLI
3004
Standard Lithium
SLI
$554M
$179K ﹤0.01%
60,535
+300
+0.5% +$1.16K
GSBD icon
3005
Goldman Sachs BDC
GSBD
$995M
$179K ﹤0.01%
13,015
+2,531
+24% +$38K
ATCO
3006
DELISTED
Atlas Corp.
ATCO
$178K ﹤0.01%
11,604
-851
-7% -$12.8K
ENLC
3007
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$178K ﹤0.01%
14,439
-1,171
-8% -$13.5K
TRAK icon
3008
ReposiTrak
TRAK
$153M
$177K ﹤0.01%
+35,750
New +$181K
HPF
3009
John Hancock Preferred Income Fund II
HPF
$344M
$177K ﹤0.01%
11,273
ATRO icon
3010
Astronics
ATRO
$3.79B
$176K ﹤0.01%
20,448
+810
+4% +$5.99K
MQY icon
3011
BlackRock MuniYield Quality Fund
MQY
$809M
$175K ﹤0.01%
15,115
-212
-1% -$2.4K
GUG
3012
Guggenheim Active Allocation Fund
GUG
$511M
$174K ﹤0.01%
12,901
+1,428
+12% +$19.6K
CTIC
3013
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$173K ﹤0.01%
28,867
+2,500
+9% +$13.6K
BAK icon
3014
Braskem
BAK
$901M
$173K ﹤0.01%
18,851
+4,165
+28% +$46.3K
SOL
3015
DELISTED
Emeren Group
SOL
$173K ﹤0.01%
38,360
-450
-1% -$2.08K
NDMO icon
3016
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$599M
$173K ﹤0.01%
17,416
-626
-3% -$6.35K
CMRC
3017
Commerce.com Inc Series 1
CMRC
$268M
$172K ﹤0.01%
19,653
-2,575
-12% -$27.9K
JMIA
3018
Jumia Technologies
JMIA
$742M
$171K ﹤0.01%
53,410
-28,406
-35% -$128K
LTRX icon
3019
Lantronix
LTRX
$266M
$171K ﹤0.01%
39,500
+18,950
+92% +$89.2K
MNP
3020
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$169K ﹤0.01%
14,509
+38
+0.3% +$437
EVGO icon
3021
EVgo
EVGO
$214M
$168K ﹤0.01%
37,639
-8,933
-19% -$57.7K
GER
3022
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$167K ﹤0.01%
13,077
+410
+3% +$5.36K
NBH
3023
Neuberger Municipal Fund Inc
NBH
$301M
$167K ﹤0.01%
15,983
+102
+0.6% +$1.06K
HROW icon
3024
Harrow
HROW
$1.49B
$166K ﹤0.01%
+11,240
New +$134K
GDO
3025
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.8M
$166K ﹤0.01%
12,967
+4
+0% +$49

Similar funds

Stifel Financial's Q4 2022 Portfolio in Review

As of Q4 2022, Stifel Financial held 3,449 positions worth $66.6B, up 9.1% from $61.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Stifel Financial's Q4 2022 filing shows 177 new, 1,464 increased, 1,530 reduced and 165 closed positions. Its largest new stake was Biohaven: 5,619,760 shares worth $78M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $464M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Stifel Financial's largest Q4 2022 buy was Biohaven: 5,619,760 shares worth $78M.
  • Stifel Financial added most to iShares US Treasury Bond ETF in Q4 2022, an estimated $362M increase.
  • Stifel Financial's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $363M.
  • Stifel Financial fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $464M.
  • Stifel Financial's ten largest holdings make up 15% of its $66.6B portfolio in Q4 2022.
  • Stifel Financial opened 177 new positions and closed 165 in Q4 2022.
  • Stifel Financial's portfolio value rose 9.1% quarter-over-quarter to $66.6B.

Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.